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Background
Infection of macaques with chimeric Simian/Human
Immunodeficiency Viruses (SHIVs) provides a powerful
model for HIV pathogenesis and vaccine development.
A limitation of the SHIVs routinely used for vaccine
studies, e.g. SHIV-1157ipd3N4, SHIV-SF162P3, and
SHIV-BaL, is that they don’t express quaternary neutra-
lization epitopes (QNEs) that are targets of broadly neu-
tralizing antibodies like PG9, PG16, and CAP256 sera.
We sought to introduce the QNEs into functional
SHIVs to study how such antibodies develop during
infection and help guide the creation of antigens capable
of eliciting such antibodies.
Methods
Pseudovirus neutralization assays were used to map the
QNE-resistance determinants of SHIV-1157ipd3N4 Env
and to test the sensitivities of mutant derivatives of SHIV-
1157ipd3N4 and SHIVSF162P3 to anti-QNE antibodies.
Full-length SHIVs expressing the mutant Envs were tested
for growth in PBMCs, and high titre stocks from those
that grew were used to infect pigtail macaques.
Results
The double mutant SHIV1157 Env, Q170K/I192R,
gained sensitivity to PG9, PG16, and CAP256 while
maintaining resistance to CD4bs and anti-V3 antibodies.
The full-length SHIV expressing this Env was able to
replicate in macaque PBMCs while maintaining sensitiv-
ity to these antibodies, indicating there was no selection
against these targets in the monkey cells. An update on
the course of infection will be provided. Six changes in
V2 (S164E, G166R, N167D, M169K, Q170K and N192R)
were required to introduce the QNEs into SHIV-
SF162P3 Env, and these dramatically increased sensitiv-
ity to anti-QNE antibodies. However, the full-length
SF162P3 SHIV carrying this mutant Env failed to grow
in macaque PBMCs; the basis of this growth defect is
being studied.
Conclusion
We created an infectious QNE-expressing SHIV with
overall neutralization phenotypes similar to those of typi-
cal primary HIV-1 isolates. This SHIV will allow the ana-
lysis of the development of anti-QNE antibody responses
during the course of infection, and should provide an
improved model for HIV-1 vaccine evaluation.
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